Sistigu, Antonella
 Distribuzione geografica
Continente #
NA - Nord America 766
EU - Europa 510
AS - Asia 103
SA - Sud America 2
Totale 1.381
Nazione #
US - Stati Uniti d'America 764
PL - Polonia 317
SE - Svezia 62
CN - Cina 54
IT - Italia 37
IE - Irlanda 31
SG - Singapore 18
GB - Regno Unito 15
DE - Germania 13
VN - Vietnam 12
FR - Francia 9
TR - Turchia 6
BE - Belgio 5
RU - Federazione Russa 5
UA - Ucraina 5
AT - Austria 4
IN - India 4
HK - Hong Kong 3
IR - Iran 3
CH - Svizzera 2
IL - Israele 2
MX - Messico 2
BR - Brasile 1
CO - Colombia 1
ES - Italia 1
FI - Finlandia 1
ID - Indonesia 1
NL - Olanda 1
NO - Norvegia 1
RO - Romania 1
Totale 1.381
Città #
Warsaw 316
Fairfield 118
Ashburn 93
Chandler 78
Woodbridge 63
Seattle 54
Cambridge 50
Redmond 47
Houston 40
Wilmington 35
Dublin 31
Ann Arbor 13
Milan 13
Dong Ket 12
Dearborn 10
Princeton 9
Singapore 8
London 7
Boston 6
Izmir 6
Jacksonville 6
New York 6
Rome 6
Brussels 5
Nanchang 5
Nanjing 5
San Mateo 5
Beijing 4
Hangzhou 4
Moscow 4
Phoenix 4
Vienna 4
Washington 4
Kunming 3
Marseille 3
Norwalk 3
Acton 2
Chicago 2
Gorgonzola 2
Herzliya 2
Hong Kong 2
Jiaxing 2
Kilburn 2
Mexico City 2
Pittsburgh 2
San Diego 2
Zurich 2
Absecon 1
Andover 1
Augusta 1
Berlin 1
Boardman 1
Bogotá 1
Cattolica 1
Changchun 1
Chiswick 1
Chongqing 1
Fabriano 1
Fremont 1
Groningen 1
Gunzenhausen 1
Hebei 1
Helsinki 1
Iasi 1
Kish 1
Las Vegas 1
Mountain View 1
Ningbo 1
Novokuznetsk 1
Nuremberg 1
Oslo 1
Pescara 1
Salò 1
Shenyang 1
Surabaya 1
São Paulo 1
Wandsworth 1
Wuhan 1
Totale 1.133
Nome #
CHK1-targeted therapy to deplete DNA replication- stressed, p53-deficient, hyperdiploid colorectal cancer stem cells 350
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 249
Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications 236
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 180
The targeting of mre11 or rad51 sensitizes colorectal cancer stem cells to chk1 inhibition 78
Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51 67
Type I interferons in infection and cancer: Unanticipated dynamics with therapeutic implications 44
Replication stress response in cancer stem cells as a target for chemotherapy 41
Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening 35
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B 29
Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy 21
The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation 19
The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure 16
Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade 11
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments 11
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death 10
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 4
Totale 1.401
Categoria #
all - tutte 5.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020406 9 34 52 115 21 34 37 19 29 14 33 9
2020/2021258 13 17 10 11 23 44 88 1 14 10 14 13
2021/2022109 14 8 4 5 5 10 4 12 8 6 17 16
2022/2023208 26 32 17 15 13 29 4 25 28 12 6 1
2023/2024199 4 51 9 30 17 14 14 2 4 9 25 20
Totale 1.401